ADBC is pleased to welcome yet another pharmaceutical company to our ever-growing network.

Meabco A/S is a Danish pharmaceutical company with anti-cancer, and radioprotection development programs. Meabco A/S is developing a product line that can provide solutions to the challenges in cancer with strong emphasis on human well-being and quality of life, and with huge potential savings on the socio-economical costs.

Read more about Meabco on www.meabco.com